Susquehanna International Group’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.16M Sell
30,252
-3,577
-11% -$492K ﹤0.01% 1483
2025
Q1
$6.1M Sell
33,829
-4,639
-12% -$836K ﹤0.01% 1018
2024
Q4
$6.03M Buy
38,468
+28,914
+303% +$4.53M ﹤0.01% 990
2024
Q3
$1.74M Buy
9,554
+4,070
+74% +$741K ﹤0.01% 1998
2024
Q2
$1.01M Sell
5,484
-96,073
-95% -$17.6M ﹤0.01% 2561
2024
Q1
$18.1M Buy
101,557
+93,515
+1,163% +$16.6M ﹤0.01% 409
2023
Q4
$998K Buy
8,042
+898
+13% +$111K ﹤0.01% 2881
2023
Q3
$829K Buy
7,144
+762
+12% +$88.4K ﹤0.01% 2803
2023
Q2
$749K Sell
6,382
-19,737
-76% -$2.32M ﹤0.01% 3093
2023
Q1
$2.09M Buy
26,119
+17,927
+219% +$1.44M ﹤0.01% 1907
2022
Q4
$649K Sell
8,192
-12,058
-60% -$955K ﹤0.01% 2857
2022
Q3
$1.41M Buy
20,250
+3,999
+25% +$279K ﹤0.01% 2075
2022
Q2
$1.07M Buy
16,251
+1,138
+8% +$74.7K ﹤0.01% 2376
2022
Q1
$1.01M Buy
15,113
+1,629
+12% +$108K ﹤0.01% 2803
2021
Q4
$943K Buy
13,484
+1,028
+8% +$71.9K ﹤0.01% 2942
2021
Q3
$650K Buy
12,456
+4,855
+64% +$253K ﹤0.01% 3342
2021
Q2
$517K Sell
7,601
-2,876
-27% -$196K ﹤0.01% 3848
2021
Q1
$807K Sell
10,477
-11,726
-53% -$903K ﹤0.01% 3258
2020
Q4
$1.33M Buy
22,203
+9,925
+81% +$595K ﹤0.01% 2196
2020
Q3
$529K Sell
12,278
-5,554
-31% -$239K ﹤0.01% 2950
2020
Q2
$739K Buy
17,832
+11,293
+173% +$468K ﹤0.01% 2491
2020
Q1
$283K Buy
+6,539
New +$283K ﹤0.01% 3479
2019
Q4
Sell
-6,630
Closed -$230K 4442
2019
Q3
$230K Buy
6,630
+416
+7% +$14.4K ﹤0.01% 3708
2019
Q2
$250K Sell
6,214
-39,279
-86% -$1.58M ﹤0.01% 3663
2019
Q1
$1.5M Buy
45,493
+26,796
+143% +$882K ﹤0.01% 1001
2018
Q4
$389K Buy
+18,697
New +$389K ﹤0.01% 2354